BioStem Technologies, Inc. (BSEM)
4.15
-0.22
(-5.03%)
USD |
OTCM |
May 06, 16:00
BioStem Technologies Free Cash Flow : 6.589M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Plus Therapeutics, Inc. | -20.84M |
| Iovance Biotherapeutics, Inc. | -336.24M |
| Protokinetix, Inc. | -0.2226M |
| GB Sciences, Inc. | -- |
| Travere Therapeutics, Inc. | -28.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 2.828M |
| Cash from Investing (Quarterly) | -0.4368M |
| Free Cash Flow Per Share (Quarterly) | 0.1423 |
| Free Cash Flow to Equity (Quarterly) | 2.447M |
| Free Cash Flow to Firm (Quarterly) | 2.391M |
| Free Cash Flow Yield | 7.65% |